Bill Gadless

Molecular Hyperselection for Optimal First-Line Targeted Therapy in RAS Wild-Type Metastatic Colorectal Cancer

Akhil Santhosh, Medical Oncology Specialist at MVR Cancer Centre and Research Institute, shared an article by Lena Weiss, et al. on X:

Molecular hyperselection for optimal choice of first-line targeted therapy independent of primary tumor sidedness: An exploratory analysis of the randomized FIRE-3 study performed in RAS wild metastatic colorectal cancer European Journal of cancer.”

Authors: Lena Weiss, Sebastian Stintzing, et al.

Molecular Hyperselection

More posts featuring Akhil Santhosh.